Mednet Logo

How do you manage a young patient with mediastinal nonseminomatous germ cell tumor that has relapsed after primary treatment with four cycles of VIP?

Community PollStarted

How do you manage a young patient with mediastinal nonseminomatous germ cell tumor that has relapsed after primary treatment with four cycles of VIP?

63 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Indiana Univ Simon Cancer Center
Answered on

Patients with primary mediastinal nonseminomatous germ cell tumors (PMNSGCT) are at poor risk regardless of the size of the tumor or amplitude of AFP. Unfortunately, second-line therapy does very poorly. There would be zero curative value for TIP or VeIP after prior VIP, of course. Despite respectab...

Join for free or sign in to see the full answer